Johnson Fistel, PLLP is investigating Unicycive Therapeutics following the FDA's issuance of a second Complete Response Letter (CRL) due to unresolved manufacturing issues. The FDA's CRL, based on deficiencies previously identified, led to a drop in Unicycive's stock price. The investigation aims to determine if Unicycive misled investors or withheld material information. Investors who suffered losses are encouraged to contact the law firm for potential recovery options.
Halper Sadeh LLC, a law firm specializing in investor rights, is investigating whether shareholders of LCI Industries, Nuvalent, Dana Incorporated, and Taylor Morrison Home Corporation are receiving fair deals in their companies' recent sales. The fi...
Breckenridge Distillery, a subsidiary of Tilray Brands, earned Double Gold and a 96-point score for its Rum Cask Finish at the New York International Spirits Competition, marking the highest honor. The distillery was also named Colorado Distillery of...
The Organic Produce Summit 2026, held July 14-16 in Monterey, California, features a comprehensive education program with industry leaders discussing sustainability, market trends, and innovations in organic produce. Highlights include a new women's ...
Crédit Agricole has acquired 100% of CAWL's capital from Worldline, shifting their partnership from a capital-based to a commercial collaboration. CAWL will continue integrating Worldline's payment acceptance solutions in its offerings, aiming to str...
Crédit Agricole has fully acquired CAWL from Worldline, transitioning their partnership from equity-based to a commercial model. CAWL will continue integrating Worldline's payment acceptance solutions, aiming to strengthen its position in French merc...
